| Literature DB >> 34373455 |
Danielle J Ingle1,2,3, Rebecca L Ambrose4,5,6, Sarah L Baines7, Sebastian Duchene7, Anders Gonçalves da Silva8, Darren Y J Lee8, Miriam Jones4,5,6, Mary Valcanis8, George Taiaroa7, Susan A Ballard8, Martyn D Kirk9, Benjamin P Howden8,7, Jaclyn S Pearson4,5,6, Deborah A Williamson10,11,12.
Abstract
Salmonella enterica serovar 4,[5],12:i:- (Salmonella 4,[5],12:i:-) is a monophasic variant of Salmonella Typhimurium that has emerged as a global cause of multidrug resistant salmonellosis. We used Bayesian phylodynamics, genomic epidemiology, and phenotypic characterization to describe the emergence and evolution of Salmonella 4,[5],12:i:- in Australia. We show that the interruption of the genetic region surrounding the phase II flagellin, FljB, causing a monophasic phenotype, represents a stepwise evolutionary event through the accumulation of mobile resistance elements with minimal impairment to bacterial fitness. We identify three lineages with different population dynamics and discrete antimicrobial resistance profiles emerged, likely reflecting differential antimicrobial selection pressures. Two lineages are associated with travel to South-East Asia and the third lineage is endemic to Australia. Moreover antimicrobial-resistant Salmonella 4,[5],12:i- lineages efficiently infected and survived in host phagocytes and epithelial cells without eliciting significant cellular cytotoxicity, suggesting a suppression of host immune response that may facilitate the persistence of Salmonella 4,[5],12:i:-.Entities:
Year: 2021 PMID: 34373455 DOI: 10.1038/s41467-021-25073-w
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919